HERRIOT TABUTEAU

Insider Reports History

Location
New York, NY
Signature
/s/ Herriot Tabuteau, M.D.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by HERRIOT TABUTEAU:

Company Role Class Num Shares Value Price $ Report Date Ownership
Axsome Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Common Stock 7,344,500 $1,341,399,480 $182.64 02 Feb 2026 Indirect
Axsome Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Restricted Stock Units 54,623 $3,749,782 $131.07 26 Feb 2026 Direct
Axsome Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Common Stock 7,229 $1,341,702 $185.60 02 Feb 2026 Direct
Axsome Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Stock Option (Right to Buy) 0 $305,172 $3.50 02 Feb 2026 Direct

Insider Reports Filed by HERRIOT TABUTEAU

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AXSM Axsome Therapeutics, Inc. 26 Feb 2026 1 $0 4 Chief Executive Officer, Director, 10%+ Owner 27 Feb 2026, 19:10
AXSM Axsome Therapeutics, Inc. 02 Feb 2026 3 -$5,755,368 4 Chief Executive Officer, Director, 10%+ Owner 02 Feb 2026, 18:30
AXSM Axsome Therapeutics, Inc. 05 Jan 2026 9 -$22,763,517 4 Chief Executive Officer, Director, 10%+ Owner 07 Jan 2026, 19:00
AXSM Axsome Therapeutics, Inc. 02 Dec 2025 9 -$11,007,199 4 Chief Executive Officer, Director, 10%+ Owner 04 Dec 2025, 19:39
AXSM Axsome Therapeutics, Inc. 03 Nov 2025 9 -$20,500,878 4 Chief Executive Officer, Director, 10%+ Owner 05 Nov 2025, 19:01
AXSM Axsome Therapeutics, Inc. 06 Oct 2025 9 -$5,054,080 4 Chief Executive Officer, Director, 10%+ Owner 08 Oct 2025, 21:08
AXSM Axsome Therapeutics, Inc. 12 Sep 2025 9 -$6,857,594 4 Chief Executive Officer, Director, 10%+ Owner 16 Sep 2025, 19:36
AXSM Axsome Therapeutics, Inc. 21 Feb 2025 3 $0 4 Chief Executive Officer, Director, 10%+ Owner 25 Feb 2025, 19:51
AXSM Axsome Therapeutics, Inc. 27 Feb 2024 2 $0 4 CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner 29 Feb 2024, 18:20
AXSM Axsome Therapeutics, Inc. 02 Mar 2023 2 $0 4 CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner 06 Mar 2023, 17:16
AXSM Axsome Therapeutics, Inc. 04 Mar 2022 2 $0 4 CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner 08 Mar 2022, 16:04